Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore

The goal of this open-label trial was to examine the efficacy and safety of a 12-week omega-3 fatty acids supplementation among children suffering with Autism Spectrum Disorders (ASD). A total of 41 children and adolescents aged 7–18 years (36 boys, 5 girls; mean age=11.66, s.d.=3.05) diagnosed with...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical nutrition 2015-08, Vol.69 (8), p.969-971
Main Authors: Ooi, Y P, Weng, S-J, Jang, L Y, Low, L, Seah, J, Teo, S, Ang, R P, Lim, C G, Liew, A, Fung, D S, Sung, M
Format: Article
Language:English
Subjects:
692/699/476
692/700/565
Adolescent
Adolescents
Attention
Autism
Autism Spectrum Disorder - blood
Autism Spectrum Disorder - drug therapy
Autism Spectrum Disorder - psychology
Behavior Rating Scale
Blood
Blood levels
Care and treatment
Child
Children
Clinical Nutrition
Clinical trials
Dietary Supplements
Disorders
Epidemiology
Fatty acids
Fatty Acids - blood
Fatty Acids, Omega-3 - therapeutic use
Female
Health aspects
Humans
Internal Medicine
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Nutrition
Omega 3 fatty acids
Pilot Projects
Public Health
short-communication
Side effects
Signs and symptoms
Singapore
Supplements
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The goal of this open-label trial was to examine the efficacy and safety of a 12-week omega-3 fatty acids supplementation among children suffering with Autism Spectrum Disorders (ASD). A total of 41 children and adolescents aged 7–18 years (36 boys, 5 girls; mean age=11.66, s.d.=3.05) diagnosed with ASD participated in the study. At post-treatment, participants showed significant improvements on all subscales of the Social Responsiveness Scale ( P
ISSN:0954-3007
1476-5640
DOI:10.1038/ejcn.2015.28